Confronting Potential Influenza A (H5N1) Pandemic with Better Vaccines

Better understanding of host-virus interaction is essential to produce effective vaccines against influenza (H5N1) viruses.

• Publication year

  2007

• Venue

  Emerging Infectious Diseases

• Publication date

  2007-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3201/eid1310.061262PMID 18258000PMCID 2851514
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Emergence and predominance of an H5N1 influenza variant in China].

  2007cited by this paper
• Influenza A Virus (H5N1) Infection in Cats Causes Systemic Disease With Potential Novel Routes of Virus Spread Within and Between HostsRimmelzwaan GF, van Riel D, Baars M, et al (Erasmus Med Ctr, Rotterdam, The Netherlands) Am J Pathol 168:176–183, 2006§

  2007cited by this paper
• Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.

  2006cited by this paper
• Silent spread of H5N1 in vaccinated poultry

  2006cited by this paper
• Improved design and intranasal delivery of an M2e-based human influenza A vaccine.

  2006cited by this paper
• Making Better Influenza Virus Vaccines?

  2006cited by this paper
• Construction and immunogenicity of recombinant fowlpox vaccines coexpressing HA of AIV H5N1 and chicken IL18.

  2006cited by this paper
• Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

  2006cited by this paper
• Influenza and the challenge for immunology

  2006cited by this paper
• Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control.

  2006cited by this paper
• Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets.

  2006cited by this paper
• Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

  2006cited by this paper
• Emergence and predominance of an H5N1 influenza variant in China

  2006cited by this paper
• Avian flu to human influenza.

  2006cited by this paper
• Protection of Mice and Poultry from Lethal H5N1 Avian Influenza Virus through Adenovirus-Based Immunization

  2006cited by this paper
• Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

  2006cited by this paper
• Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

  2006cited by this paper
• Amid Mayhem in Turkey, Experts See New Chances for Research

  2006influential reference
• Avian influenza. Human transmission but no pandemic in Indonesia.

  2006cited by this paper
• Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

  2006cited by this paper
• Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses.

  2006cited by this paper
• Human Transmission But No Pandemic in Indonesia

  2006cited by this paper
• Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

  2005cited by this paper
• Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses.

  2005cited by this paper
• Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus

  2005cited by this paper
• Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

  2005cited by this paper
• Virus-Like Particle (VLP) Vaccine Conferred Complete Protection against a Lethal Influenza Virus Challenge

  2005cited by this paper
• Preparing for the next pandemic.

  2005cited by this paper
• Newer respiratory virus infections: human metapneumovirus, avian influenza virus, and human coronaviruses

  2005cited by this paper
• Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines.

  2005cited by this paper
• Does influenza vaccination exacerbate asthma in children?

  2004cited by this paper
• Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys.

  2004cited by this paper
• Confronting the avian influenza threat: vaccine development for a potential pandemic

  2004cited by this paper
• Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine.

  2004cited by this paper
• Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2.

  2003cited by this paper
• Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

  2002cited by this paper
• Lethal H5N1 influenza viruses escape host anti-viral cytokine responses

  2002cited by this paper
• Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children.

  2002cited by this paper
• Influenza A virus with defective M2 ion channel activity as a live vaccine.

  2002cited by this paper
• Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents.

  2000cited by this paper
• Distinct Pathogenesis of Hong Kong-Origin H5N1 Viruses in Mice Compared to That of Other Highly Pathogenic H5 Avian Influenza Viruses

  2000cited by this paper
• A universal influenza A vaccine based on the extracellular domain of the M2 protein

  1999cited by this paper

• SARS-CoV-2 S, M, and E Structural Glycoproteins Differentially Modulate Endoplasmic Reticulum Stress Responses

  2025cites this paper
• The Role of the Nuclear Factor-Kappa B (NF-κB) Pathway in SARS-CoV-2 Infection

  2024cites this paper
• Two Decades of Arrayed Imaging Reflectometry for Sensitive, High-Throughput Biosensing

  2023cites this paper
• Docking-based workflow and ADME prediction of some compounds in Curcuma longa and Andrographis paniculata as polymerase PA-PB1 inhibitors of influenza A/H5N1 virus

  2023cites this paper
• Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality

  2021cites this paper
• Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2

  2021cites this paper
• JAK1 inhibition blocks lethal sterile immune responses: implications for COVID-19 therapy

  2020cites this paper
• Hypercytokinemia and Pathogen–Host Interaction in COVID-19

  2020cites this paper
• Down Syndrome and COVID-19: A Perfect Storm?

  2020cites this paper
• E↵orts at COVID-19 Vaccine Development: Challenges and Successes

  2020cites this paper
• Efforts at COVID-19 Vaccine Development: Challenges and Successes

  2020cites this paper
• Age, period, and cohort effects on adult mortality due to extrinsic causes of death

  2020cites this paper
• Determinants of Influenza Mortality Trends: Age-Period-Cohort Analysis of Influenza Mortality in the United States, 1959–2016

  2019influential citation
• Influenza A(H5N1) Virus Subunit Vaccine Administered with CaPNP Adjuvant Induce High Virus Neutralization Antibody Titers in Mice

  2019cites this paper
• Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells

  2018cites this paper
• A Review of Zika Virus: Hurdles toward Vaccine Development and the Way Forward

  2018cites this paper
• Risk of Severe Influenza Infection: Hypercytokinemia Gene Polymorphisms and Related Plasma Proteome in Canadian Young Adults

  2017cites this paper
• Partial heterologous protection by low pathogenic H9N2 virus against natural H9N2-PB1 gene reassortant highly pathogenic H5N1 virus in chickens.

  2016cites this paper
• Curcumin suppression of cytokine release and cytokine storm. A potential therapy for patients with Ebola and other severe viral infections.

  2015cites this paper
• The role of C5a in acute lung injury induced by highly pathogenic viral infections

  2015cites this paper
• Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks

  2015cites this paper
• Global distribution patterns of highly pathogenic H5N1 avian influenza: environmental vs. socioeconomic factors.

  2014cites this paper
• Concurrent Measurement of Dynamic Changes in Viral Load, Serum Enzymes, T Cell Subsets, and Cytokines in Patients with Severe Fever with Thrombocytopenia Syndrome

  2014cites this paper
• Development of a vectored equine herpesvirus type 1 (EHV-1) vaccine against pandemic influenza A virus (09/H1N1)

  2013cites this paper
• Development of a vectored equine herpesvirus type 1 (EHV-1) vaccine against pandemic influenza A virus (09/H1N1)

  2013cites this paper
• Population genetic tools for dissecting innate immunity in humans

  2013cites this paper
• Dynamics of a Cytokine Storm

  2012cites this paper
• An equine herpesvirus 1 (EHV-1) vectored H1 vaccine protects against challenge with swine-origin influenza virus H1N1.

  2011cites this paper
• Isolation, cloning, and sequencing of influenza A (H1N1) hemagglutinin for production of hemagglutinin gene bank

  2011cites this paper
• Glycosylation at 158N of the Hemagglutinin Protein and Receptor Binding Specificity Synergistically Affect the Antigenicity and Immunogenicity of a Live Attenuated H5N1 A/Vietnam/1203/2004 Vaccine Virus in Ferrets

  2010cites this paper
• Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza.

  2009cites this paper
• MASTER OF MILITARY ART AND SCIENCE Homeland Security

  2009cites this paper
• Evolutionary and Transmission Dynamics of Reassortant H5N1 Influenza Virus in Indonesia

  2008cites this paper
• Pandemic and seasonal influenza: therapeutic challenges.

  2008cites this paper
• New developments in vaccines against respiratory viruses.

  2008cites this paper